Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
6
Mins
20 Nov 2018
Editor's Pick: How Can We Develop More Effective Strategies for Type 2 Diabetes Mellitus Prevention? A Paradigm Shift from a Glucose-Centric to a Beta Cell-Centric Concept of Diabetes
This thought-provoking paper by Saisho provides a very accessible discussion of the shift from a glucose-centric to a beta cell-centric understanding…
2
Mins
20 Nov 2018
Abdominal Subcutaneous Adipose Tissue Gene Expression in Relation to Tissue-Specific Insulin Resistance in Human Obesity
Obesity and being overweight are major risk factors for several diseases, including cardiovascular disease and Type 2 diabetes mellitus. Adipose tissue…
11
Mins
20 Nov 2018
Update on the Management of Diabetic Dyslipidaemia
Diabetic dyslipidaemia is characterised by low levels of HDL-C, elevated levels of LDL-C, and a high prevalence of small dense LDL particles
9
Mins
20 Nov 2018
Efficacy of Wearable Devices to Measure and Promote Physical Activity in the Management of Diabetes
Physical inactivity is a global health problem that contributes to the increasing risk of obesity and diabetes. Wearable devices are defined as…
2
Mins
20 Nov 2018
Variants in Genes (DHCR7, CYP2R1, and GC) Regulating Vitamin D Metabolism Determine Low Vitamin D Levels in Type 2 Diabetic Patients
Hypovitaminosis D is associated with an increased prevalence and incidence of metabolic syndrome and Type 2 diabetes mellitus (T2DM).
2
Mins
20 Nov 2018
High Low-Density Lipoprotein Cholesterol Levels and Risk of Peripheral Vascular Diseases: A Mendelian Randomisation Study Including 116,419 Individuals From The General Population
High low-density lipoprotein (LDL) cholesterol levels are causally involved in the pathogenesis of atherosclerosis and are related to an increased risk…
10
Mins
20 Nov 2018
Low-Carbohydrate Diets and Glycaemic Control in Type 1 Diabetes Mellitus
In recent years the successful treatment of Type 2 diabetes mellitus through total calorific and/or dietary carbohydrate restriction has been well…
11
Mins
20 Nov 2018
Growth Hormone and Metabolic Homeostasis
This review provides an overview of the effects of pituitary growth hormone (GH) on glucose, lipid, and protein metabolism, insulin resistance, and metabolic homeostasis.
2
Mins
20 Nov 2018
Inhibition of Insulin Secretion by Cxcl14
G protein-coupled receptors are tractable targets for pharmacotherapies;1 however, challenges arise when it is necessary to either deorphanise a known…
10
Mins
20 Nov 2018
Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Efficacy and Safety in the Treatment of Hypercholesterolaemia
Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9I) are a new class of medication that has recently arisen to combat hypercholesterolaemia.
←
1
2
3
…
15
16
17
18
19
20
21
…
151
152
153
→